| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.5 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |